ID
20446
Description
An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants; ODM derived from: https://clinicaltrials.gov/show/NCT00528528
Link
https://clinicaltrials.gov/show/NCT00528528
Keywords
Versions (1)
- 2/22/17 2/22/17 -
Uploaded on
February 22, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Hepatitis C NCT00528528
Eligibility Chronic Hepatitis C NCT00528528
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
contraindication for starting anti-hcv therapy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C4020634
Description
Medical History; Liver Cirrhosis; Decompensated liver disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0023890
- UMLS CUI [1,3]
- C4075847
Description
comorbidity, liver disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0023895
Description
hiv, hep b
Data type
boolean
Alias
- UMLS CUI [1]
- C0019682
- UMLS CUI [2]
- C0019163
Description
Pregnancy; Childbearing Potential; Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C3831118
- UMLS CUI [1,3]
- C0006147
Similar models
Eligibility Chronic Hepatitis C NCT00528528
- StudyEvent: Eligibility
C3532919 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,2])
C4020634 (UMLS CUI [1,2])
C0023890 (UMLS CUI [1,2])
C4075847 (UMLS CUI [1,3])
C0023895 (UMLS CUI [1,2])
C0019163 (UMLS CUI [2])
C3831118 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,3])